ArticleBritish journal of clinical pharmacology2026

Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results.

Eline van Maanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.